Ciclosporina en el tratamiento del lupus eritematoso sistématico grave.
M. A. Frutos, M. González-Molina, P. Aranda, M. Cabello, G. Martín-Reyes, A. Valera, B. Ramos, A. Ruiz y E. López de Novales.
Leído
9973
Vecesse ha leído el artículo
5281
Total PDF
4692
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 44 | 43 | 87 |
| 2025 5 | 79 | 68 | 147 |
| 2025 4 | 68 | 82 | 150 |
| 2025 3 | 46 | 53 | 99 |
| 2025 2 | 58 | 76 | 134 |
| 2025 1 | 58 | 67 | 125 |
| 2024 12 | 40 | 57 | 97 |
| 2024 11 | 43 | 83 | 126 |
| 2024 10 | 82 | 96 | 178 |
| 2024 9 | 55 | 86 | 141 |
| 2024 8 | 52 | 89 | 141 |
| 2024 7 | 39 | 87 | 126 |
| 2024 6 | 69 | 431 | 500 |
| 2024 5 | 72 | 120 | 192 |
| 2024 4 | 59 | 83 | 142 |
| 2024 3 | 48 | 92 | 140 |
| 2024 2 | 42 | 81 | 123 |
| 2024 1 | 47 | 85 | 132 |
| 2023 12 | 43 | 57 | 100 |
| 2023 11 | 33 | 76 | 109 |
| 2023 10 | 75 | 85 | 160 |
| 2023 9 | 89 | 78 | 167 |
| 2023 8 | 46 | 62 | 108 |
| 2023 7 | 84 | 74 | 158 |
| 2023 6 | 39 | 78 | 117 |
| 2023 5 | 74 | 68 | 142 |
| 2023 4 | 44 | 68 | 112 |
| 2023 3 | 56 | 66 | 122 |
| 2023 2 | 41 | 53 | 94 |
| 2022 1 | 24 | 54 | 78 |
| 2022 12 | 21 | 47 | 68 |
| 2022 11 | 23 | 49 | 72 |
| 2022 10 | 42 | 85 | 127 |
| 2022 9 | 39 | 67 | 106 |
| 2022 8 | 25 | 68 | 93 |
| 2022 7 | 32 | 62 | 94 |
| 2022 6 | 33 | 69 | 102 |
| 2022 5 | 30 | 56 | 86 |
| 2022 4 | 38 | 92 | 130 |
| 2022 3 | 38 | 81 | 119 |
| 2022 2 | 22 | 73 | 95 |
| 2021 1 | 19 | 70 | 89 |
| 2021 12 | 28 | 65 | 93 |
| 2021 11 | 26 | 67 | 93 |
| 2021 10 | 27 | 83 | 110 |
| 2021 9 | 25 | 66 | 91 |
| 2021 8 | 17 | 43 | 60 |
| 2021 7 | 32 | 60 | 92 |
| 2021 6 | 28 | 69 | 97 |
| 2021 5 | 26 | 48 | 74 |
| 2021 4 | 46 | 120 | 166 |
| 2021 3 | 60 | 61 | 121 |
| 2021 2 | 60 | 61 | 121 |
| 2020 1 | 30 | 75 | 105 |
| 2020 12 | 25 | 50 | 75 |
| 2020 11 | 22 | 41 | 63 |
| 2020 10 | 31 | 52 | 83 |
| 2020 9 | 47 | 53 | 100 |
| 2020 8 | 30 | 25 | 55 |
| 2020 7 | 47 | 49 | 96 |
| 2020 6 | 37 | 41 | 78 |
| 2020 5 | 44 | 36 | 80 |
| 2020 4 | 32 | 55 | 87 |
| 2020 3 | 33 | 43 | 76 |
| 2020 2 | 31 | 54 | 85 |
| 2020 1 | 47 | 65 | 112 |
| 2019 12 | 26 | 11 | 37 |
| 2019 11 | 46 | 24 | 70 |
| 2019 10 | 27 | 34 | 61 |
| 2019 9 | 60 | 61 | 121 |
| 2019 8 | 19 | 36 | 55 |
| 2019 7 | 27 | 35 | 62 |
| 2019 6 | 23 | 40 | 63 |
| 2019 5 | 28 | 59 | 87 |
| 2019 4 | 75 | 52 | 127 |
| 2019 3 | 21 | 15 | 36 |
| 2019 2 | 30 | 35 | 65 |
| 2019 1 | 16 | 13 | 29 |
| 2018 12 | 27 | 12 | 39 |
| 2018 11 | 7 | 0 | 7 |
| 2018 10 | 44 | 0 | 44 |
| 2018 9 | 27 | 3 | 30 |
| 2018 8 | 24 | 3 | 27 |
| 2018 7 | 18 | 1 | 19 |
| 2018 6 | 18 | 1 | 19 |
| 2018 5 | 14 | 0 | 14 |
| 2018 4 | 19 | 0 | 19 |
| 2018 3 | 20 | 0 | 20 |
| 2018 2 | 8 | 0 | 8 |
| 2018 1 | 22 | 1 | 23 |
| 2017 12 | 12 | 1 | 13 |
| 2017 11 | 21 | 0 | 21 |
| 2017 10 | 22 | 1 | 23 |
| 2017 9 | 14 | 1 | 15 |
| 2017 8 | 20 | 0 | 20 |
| 2017 7 | 14 | 0 | 14 |
| 2017 6 | 19 | 7 | 26 |
| 2017 5 | 22 | 0 | 22 |
| 2017 4 | 16 | 0 | 16 |
| 2017 3 | 25 | 1 | 26 |
| 2017 2 | 39 | 0 | 39 |
| 2016 1 | 18 | 4 | 22 |
| 2016 12 | 39 | 5 | 44 |
| 2016 11 | 44 | 7 | 51 |
| 2016 10 | 54 | 8 | 62 |
| 2016 9 | 72 | 1 | 73 |
| 2016 8 | 129 | 7 | 136 |
| 2016 7 | 92 | 3 | 95 |
| 2016 6 | 57 | 0 | 57 |
| 2016 5 | 47 | 0 | 47 |
| 2016 4 | 37 | 0 | 37 |
| 2016 3 | 33 | 0 | 33 |
| 2016 2 | 46 | 0 | 46 |
| 2015 1 | 47 | 0 | 47 |
| 2015 12 | 41 | 0 | 41 |
| 2015 11 | 33 | 0 | 33 |
| 2015 10 | 38 | 0 | 38 |
| 2015 9 | 42 | 0 | 42 |
| 2015 8 | 29 | 0 | 29 |
| 2015 7 | 24 | 0 | 24 |
| 2015 6 | 16 | 0 | 16 |
| 2015 5 | 40 | 0 | 40 |
| 2015 4 | 2 | 0 | 2 |
Mostrar todo
